dr. rini describes axitinib's and sorafenib's side effects
Published 13 years ago • 1.1K plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
0:38
dr. rini explains the axitinib integration process
-
0:43
dr. rini on the results from his axitinib and sorafenib trial
-
1:19
dr. rini on the efficacy of axitinib and pembrolizumab in rcc
-
0:44
dr. rini on the axitinib and sorafenib trial vegf focus
-
0:36
dr. rini on the axitinib and sorafenib trial hazard ratio
-
0:43
dr. rini discusses the vegf targeted agent axitinib
-
5:22
theory of iridology
-
4:01
insulin and diabetes
-
43:31
advances in left main bifurcation pci and renal denervation - aict-asiapcr 2022
-
0:53
dr. rini on standards of care for advanced rcc
-
1:34
dr. rini on pembrolizumab plus axitinib in rcc
-
2:32
avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
-
1:20
dr. cella on the side effect focus of the axitinib and sorafenib trial
-
1:03
dr. rini on managing the toxicity of pembrolizumab plus axitinib in mrcc
-
1:04
dr. rini discusses pembrolizumab plus axitinib in mrcc
-
7:42
dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma
-
2:11
dr. cella discusses axitinib and sorafenib axis trial
-
0:45
dr. rini on the progression of advanced rcc therapy
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
2:06
dr. rini discusses tivozanib in advanced rcc
-
4:25
kidney cancer updates: avelumab/axitinib, pembro/axitinib, bevacizumab/atezo & ipilimumab/nivo
-
8:32
axitinib: unraveling its mechanism of action, life-changing uses, and side effects